Silica network improve the effect of fludarabine and paclitaxel on HCT8 cell line

Romanian Journal of Morphology and Embryology

Volumn 55, Issue 2 SUPPL., 2014, Pages 545-551

  Voicu, Georgeta ^a   Adrian, Gabriel Anghel ^a   Badea, Mihaela ^a   Bordei, Emanoil ^a   Crantea, Georgiana ^a   Raluca, Ionela Gavrilǎ ^a   Grecu, Alexandru ^a   Ana Maria Jercan, Denisa ^a   Bogdan, Cristian Nicolae ^a   Greta, Cristina Vochiţoaia ^a   Tchinda, Kuete ^a   Alina, Maria Holban ^a   Bleotu, Coralia ^b   Alexandru, Mihai Grumezescu ^a  

^a UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^b STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

Author keywords

Antitumoral; Cell viability; Fludarabine; Paclitaxel; Silica network

Indexed keywords

BIOMATERIAL; FLUDARABINE; PACLITAXEL; SILICON DIOXIDE; VIDARABINE;

ANALOGS AND DERIVATIVES; CELL SHAPE; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; HUMAN; INFRARED SPECTROPHOTOMETRY; METABOLISM; SCANNING ELECTRON MICROSCOPY; TUMOR CELL CULTURE; X RAY DIFFRACTION;

BIOCOMPATIBLE MATERIALS; CELL SHAPE; ENDOTHELIAL CELLS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PACLITAXEL; SILICON DIOXIDE; SPECTROPHOTOMETRY, INFRARED; TUMOR CELLS, CULTURED; VIDARABINE; X-RAY DIFFRACTION;

EID: 84906729203     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Santhosh PB, Ulrih NP, Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics, Cancer Lett, 2013, 336(1):8-17.
2. Mattu C, Pabari RM, Boffito M, Sartori S, Ciardelli G, Ramtoola Z, Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells, Eur J Pharm Biopharm, 2013, 85(3 Pt A):463-472.
3. Oh IH, Min HS, Li L, Tran TH, Lee YK, Kwon IC, Choi K, Kim K, Huh KM, Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice, Biomaterials, 2013, 34(27): 6454-6463.
4. Aravind A, Nair R, Raveendran S, Veeranarayanan S, Nagaoka Y, Fukuda T, Hasumura T, Morimoto H, Yoshida Y, Maekawa T, Kumar DS, Aptamer conjugated paclitaxel and magnetic fluid loaded fluorescently tagged PLGA nanoparticles for targeted cancer therapy, J Magn Magn Mater, 2013, 344:116-123.
5. Aznar MÁ, Lasa-Saracíbar B, Hermoso de Mendoza AE, Blanco-Prieto MJ, Efficacy of edelfosine lipid nanoparticles in breast cancer cells, Int J Pharm, 2013, 454(2):720-726.
6. Xu P, Yin Q, Shen J, Chen L, Yu H, Zhang Z, Li Y, Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS, Int J Pharm, 2013, 454(1): 21-30.
7. Tran NTT, Wang TH, Lin CY, Tai Y, Synthesis of methotrexateconjugated gold nanoparticles with enhanced cancer therapeutic effect, Biochem Eng J, 2013, ():175-180.
8. Badr G, Al-Sadoon MK, Rabah DM, Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer-and prostate cancer-bearing experimental mouse models, Free Radic Biol Med, 2013, 65:175-189.
9. Xiao J, Duan X, Yin Q, Miao Z, Yu H, Chen C, Zhang Z, Wang Y, Li Y, The inhibition of metastasis and growth of breast cancer by blocking the NF-κB signaling pathway using bioreducible PEI-based/p65 shRNA complex nanoparticles, Biomaterials, 2013, 34(21):5381-5390.
10. Le Broc-Ryckewaert D, Carpentier R, Lipka E, Daher S, Vaccher C, Betbeder D, Furman C, Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells, Int J Pharm, 2013, 454(2):712-719.
11. Behnam B, Shier WT, Nia AH, Abnous K, Ramezani M, Non-covalent functionalization of single-walled carbon nanotubes with modified polyethyleneimines for efficient gene delivery, Int J Pharm, 2013, 454(1):204-215.
12. Huang J, Gou G, Xue B, Yan Q, Sun Y, Dong LE, Preparation and characterization of "dextran-magnetic layered double hydroxide-fluorouracil" targeted liposomes, Int J Pharm, 2013, 450(1-2):323-330.
13. Al-Nahain A, Lee SY, In I, Lee KD, Park SY, Triggered pH/redox responsive release of doxorubicin from prepared highly stable graphene with thiol grafted Pluronic, Int J Pharm, 2013, 450(1-2):208-217.
14. Schleich N, Sibret P, Danhier P, Ucakar B, Laurent S, Muller RN, Jérôme C, Gallez B, Préat V, Danhier F, Dual anticancer drug/superparamagnetic iron oxide-loaded PLGAbased nanoparticles for cancer therapy and magnetic resonance imaging, Int J Pharm, 2013, 447(1-2):94-101.
15. Hiorth M, Liereng L, Reinertsen R, Tho I, Formulation of bioadhesive hexylaminolevulinate pellets intended for photodynamic therapy in the treatment of cervical cancer, Int J Pharm, 2013, 441(1-2):544-554.
16. Talekar M, Ganta S, Amiji M, Jamieson S, Kendall J, Denny WA, Garg S, Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy, Int J Pharm, 2013, 450(1-2):278-289.
17. Larson N, Yang J, Ray A, Cheney DL, Ghandehari H, Kopeček J, Biodegradable multiblock poly(N-2-hydroxypropyl) methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment, Int J Pharm, 2013, 454(1):435-443.
18. Rivera-Rodriguez GR, Lollo G, Montier T, Benoit JP, Passirani C, Alonso MJ, Torres D, In vivo evaluation of poly-lasparagine nanocapsules as carriers for anti-cancer drug delivery, Int J Pharm, 2013, 458(1):83-89.
19. Fleming RA, Zou M, Silica nanoparticle-based films on titanium substrates with long-term superhydrophilic and superhydrophobic stability, Appl Surf Sci, 2013, 280:820-827.
20. Ashraful Alam M, Takafuji M, Ihara H, Thermosensitive hybrid hydrogels with silica nanoparticle-cross-linked polymer networks, J Colloid Interface Sci, 2013, 405:109-117.
21. Li H, Zhang JZ, Tang Q, Du M, Hu J, Yang D, Reductionresponsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell, Mater Sci Eng C, 2013, 33(6):3426-3431.
22. Wen H, Guo J, Chang B, Yang W, pH-responsive composite microspheres based on magnetic mesoporous silica nanoparticle for drug delivery, Eur J Pharm Biopharm, 2013, 84(1):91-98.
23. Tao L, Song C, Sun Y, Li X, Li Y, Jin B, Zhang Z, Yang K, A fluorescent and chemiluminescent difunctional mesoporous silica nanoparticle as a label for the ultrasensitive detection of cancer cells, Anal Chim Acta, 2013, 761:194-200.
24. Badruddoza AZ, Rahman MT, Ghosh S, Hossain MZ, Shi J, Hidajat K, Uddin MS, β-Cyclodextrin conjugated magnetic, fluorescent silica core-shell nanoparticles for biomedical applications, Carbohydr Polym, 2013, 95(1):449-457.
25. He H, Wang J, Gao Q, Chang M, Ren Z, Zhang X, Li X, Weng W, Han G, Ag-silica composite nanotube with controlled wall structures for biomedical applications, Colloids Surf B Biointerfaces, 2013, 111C:693-698.
26. Chen X, Core/shell structured silica spheres with controllable thickness of mesoporous shell and its adsorption, drug storage and release properties, Colloids Surf A Physicochem Eng Asp, 2013, 428:79-85.
27. Lei C, Chen B, Li X, Qi W, Liu J, Non-destructively shattered mesoporous silica for protein drug delivery, Microporous Mesoporous Mater, 2013, 175:157-160.
28. Zhou H, Sun J, Wu X, Ren B, Wang J, Tailored morphology and controlled structure of bimodal mesopores silicas via additive ammonia amount in the TEOS-CTAB-H2O system, Mater Chem Phys, 2013, 140(1):148-153.
29. Grumezescu AM, Andronescu E, Ficai A, Voicu G, Cocos O, Chifiriuc MC, Eugenia cayophyllata essential oil-SiO2 biohybrid structure for the potentiation of antibiotics activity, Rom J Mater, 2013, 43(2):160-166.
30. Zhang C, Yan H, Kai Lv, Yuan S, Facile synthesis of hierarchically porous silica nanocapsules and nanospheres via vesicle templating, Colloids Surf A Physicochem Eng Asp, 2013, 424:59-65.
31. Soulé S, Allouche J, Dupin JC, Martinez H, Design of Ag-Au nanoshell core/mesoporous oriented silica shell nanoparticles through a sol-gel surfactant templating method, Microporous Mesoporous Mater, 2013, 171:72-77.
32. Grumezescu AM, Ghitulica CD, Voicu G, Huang KS, Yang CH, Ficai A, Vasile BS, Grumezescu V, Bleotu C, Chifiriuc MC, New silica nanostructure for the improved delivery of topical antibiotics used in the treatment of staphylococcal cutaneous infections, Int J Pharm, 2014, 463(2):170-176.
33. Grumezescu AM, Ghitulica CD, Voicu G, Huang KS, Yang CH, Ficai A, Vasile BS, Grumezescu V, Bleotu C, Chifiriuc MC, Fludarabine, Drugs.com, www.drugs.com/pro/fludarabine, 2000-2014.
34. Saville MW, Lietzau J, Pluda JM, Feuerstein I, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg SM, Broder S et al., Treatment of HIV-associated Kaposi's sarcoma with paclitaxel, Lancet, 1995, 346(8966):26-28.
35. Ozcelik B, Turkyilmaz C, Ozgun MT, Serin IS, Batukan C, Ozdamar S, Ozturk A, Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist, Fertil Steril, 2010, 93(5):1609-1614.